The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.25
Bid: 1.10
Ask: 1.40
Change: 0.00 (0.00%)
Spread: 0.30 (27.273%)
Open: 1.25
High: 1.25
Low: 1.25
Prev. Close: 1.25
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Physiomics wins contract with Japan-based Astellas Pharma

Fri, 31st Jul 2020 12:08

(Sharecast News) - Oncology consultancy Physiomics announced on Friday that it has been awarded a contract by a new client, Japan-based global pharmaceutical company Astellas Pharma.
The AIM-traded firm said the contract was for a modelling project involving its 'Virtual Tumour' immuno-oncology model, and related to an undisclosed Astellas asset.

It said the work was expected to be completed this calendar year.

The precise value of the contract could not be disclosed due to commercial confidentiality, but the board said it was around 20% of the company's last full-year total income to 30 June 2019.

"We are delighted to have been awarded this contract by Astellas, a global pharmaceutical company with a strong oncology focus," said chief executive officer Dr Jim Millen.

"We look forward to working with this important new client to support its oncology development activities."

At 0944 BST, shares in Physiomics were down 17.09% at 7.71p.
More News
12 Nov 2014 10:47

Physiomics Optimistic On Virtual Tumour Platform Interest

Read more
4 Nov 2014 12:10

UK MIDDAY BRIEFING: Oil Stocks Down As Oil Price Hits 4-Year Low

Read more
4 Nov 2014 11:32

UK WINNERS & LOSERS: Imperial Tobacco Gains As Oil Stocks Slide

Read more
4 Nov 2014 08:27

Physiomics Shares Jump On Disclosure Of Merck As Partner

Read more
4 Nov 2014 08:21

UK MORNING BRIEFING: Legal & General, Imperial Tobacco Start Strongly

Read more
27 Oct 2014 11:11

UK WINNERS & LOSERS: Banks Under Stress After EU Test Results

Read more
27 Oct 2014 10:16

Physiomics Extends Collaboration With "Major" Pharmaceutical Company

Read more
7 Oct 2014 08:51

Physiomics Launches Web-Based Cardiac Toxicity Prediction Service

Read more
14 Aug 2014 15:41

Physiomics wins cancer therapy deal

Biology company Physiomics won a contract with an unidentified drug company on Thursday, boosting its shares by 18.75%. Under the deal, Physiomics will model immune therapy agents for cancer research by the end of the year on a fee-for-service basis. Physiomics' chief executive Mark Shadwick said:

Read more
14 Aug 2014 12:20

Physiomics Wins Contract With Undisclosed Pharmaceutical Company

Read more
12 Jun 2014 12:24

Physiomics Shares Surge On Diatech Pharmacogenetics Collaboration

LONDON (Alliance News) - Shares in Physiomics PLC surged Thursday, after it said it has signed a head of terms agreement for a new collaboration with Diatech Pharmacogenetics srl. The Oxford-based systems biology company said that, under the terms of the expected collaboration agreement, th

Read more
10 Apr 2014 12:30

UK MIDDAY BRIEFING: Same Problems For M&S, WH Smith

LONDON (Alliance News) - Retailers Marks & Spencer and WH Smith Thursday reported better performances than of late, but still saw their shares decline as analysts worried that they still have a lot to do to fix their long-standing issues.

Marks

Read more
10 Apr 2014 10:57

UK WINNERS & LOSERS: M&S, WH Smith Drop Sharply After Early Strength

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday. ------- FTSE 100 - WINNERS ------- Resolution, up 1%. The firm said its insurance and pensions provider Friends Life is scrapping active member

Read more
10 Apr 2014 08:02

Physiomics To Show New Validation For Virtual Tumour Platform

LONDON (Alliance News) - Physiomics PLC said Thursday that it will be demonstrating a new validation of its Virtual Tumour Clinical Platform at a workshop in France, with a study that shows the platform can be used to make accurate predictions of clinical outcomes. The Virtual Tumour Clinic

Read more
3 Apr 2014 11:17

Physiomics In Talks With Pharmaceutical Companies For VTC Platform

LONDON (Alliance News) - Physiomics PLC said Thursday that it is in discussions with pharmaceutical companies about starting the first project to use its Virtual Tumour Clinical platform to predict outcomes for a new pipeline drug. It will be presenting the first validation of its Virtual T

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.